Exhibit 1

JOINT FILING AGREEMENT

Each of the undersigned agrees that (i) the statement on Schedule 13G relating to the Common Stock of AxoGen, Inc., has been adopted and filed on behalf of each of them, (ii) all future amendments to such statement on Schedule 13G/A will, unless written notice to the contrary is delivered as described below, be jointly filed on behalf of each of them, and (iii) the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934 apply to each of them. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signature hereto, at the principal office thereof.

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Date: February 9, 2021

 

EW HEALTHCARE PARTNERS L.P.						INDIVIDUALS:
By: Essex Woodlands Fund IX-GP, L.P.,
Its General Partner
								/s/ Martin P. Sutter
By: Essex Woodlands IX, LLC,						Name:		Martin P. Sutter
		Its General Partner
By:		/s/ Martin P. Sutter						/s/ R. Scott Barry
		Name: Martin P. Sutter				Name:		R. Scott Barry
		Title:   Managing Director
ESSEX WOODLANDS FUND IX-GP, L.P.   By: Essex Woodlands IX, LLC,								/s/ Ronald Eastman Name: Ronald Eastman
Its General Partner
								/s/ Petri Vainio
By:		/s/ Martin P. Sutter						Name: Petri Vainio
		Name: Martin P. Sutter
		Title:   Managing Director
ESSEX WOODLANDS IX, LLC
		/s/ Martin P. Sutter
Name:		Martin P. Sutter
Title:		Managing Director